Centric Wealth Management’s AstraZeneca AZN Stock Holding History

Centric Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,018	Closed	-$242K	–	154
2021 Q3	$242K	Hold	2,018	–	–	0.09%	135
2021 Q2	$242K	Buy	+2,018	New	+$221K	0.08%	133

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Centric Wealth Management's AZN Position: Q4 2021 in Review

Centric Wealth Management sold out of AstraZeneca (AZN) in Q4 2021, closing a stake of 2,018 shares — an estimated $242K sold.

Centric Wealth Management first reported a position in AZN in Q2 2021 and held it in 2 quarters. The position peaked at $242K in Q3 2021. 949 funds tracked by Wall St. Rank hold AZN as of Q4 2021.

Centric Wealth Management reported no remaining AstraZeneca position as of Q4 2021 after selling out during the quarter.
Centric Wealth Management sold 2,018 AstraZeneca shares in Q4 2021, an estimated $242K.
Centric Wealth Management first reported a position in AstraZeneca in Q2 2021 and held it in 2 quarters.
Centric Wealth Management's AstraZeneca position peaked at $242K in Q3 2021.
949 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2021.

Based on Centric Wealth Management's 13F filing for Q4 2021, filed 27 Jan 2022.